OTCMKTS:UDHCF - UDG Healthcare Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$14.79
+0.30 (1.20%)

This chart shows the closing price for UDHCF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New UDG Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UDHCF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UDHCF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for UDG Healthcare in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $14.79.

This chart shows the closing price for UDHCF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 5 investment analysts is to hold stock in UDG Healthcare. This rating has held steady since October 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/13/2021Jefferies Financial GroupUpgradeUnderperform ➝ Hold
5/13/2021Berenberg BankDowngradeBuy ➝ Hold
5/6/2021BarclaysReiterated RatingOverweight
11/11/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform
11/9/2020Jefferies Financial GroupDowngradeHold ➝ Underperform
10/2/2020Stifel NicolausDowngradeBuy ➝ Hold
3/20/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform
4/4/2019BarclaysUpgradeEqual Weight ➝ Overweight
(Data available from 7/23/2016 forward)
UDG Healthcare logo
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is heaquartered in Dublin, the Republic of Ireland.
Read More

Today's Range

Now: $14.79
Low: $14.79
High: $14.79

50 Day Range

MA: $12.75
Low: $11.63
High: $14.79

52 Week Range

Now: $14.79
Low: $10.86
High: $14.79

Volume

N/A

Average Volume

4,793 shs

Market Capitalization

$3.68 billion

P/E Ratio

30.81

Dividend Yield

1.27%

Beta

0.67

Frequently Asked Questions

What sell-side analysts currently cover shares of UDG Healthcare?

The following Wall Street analysts have issued research reports on UDG Healthcare in the last year: Barclays PLC, Berenberg Bank, Jefferies Financial Group Inc., Royal Bank of Canada, Stifel Nicolaus, and Zacks Investment Research.
View the latest analyst ratings for UDHCF.

What is the current price target for UDG Healthcare?

0 Wall Street analysts have set twelve-month price targets for UDG Healthcare in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for UDG Healthcare in the next year.
View the latest price targets for UDHCF.

What is the current consensus analyst rating for UDG Healthcare?

UDG Healthcare currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in UDHCF, but not buy more shares or sell existing shares.
View the latest ratings for UDHCF.

What other companies compete with UDG Healthcare?

How do I contact UDG Healthcare's investor relations team?

UDG Healthcare's physical mailing address is 20 Riverwalk Citywest Business Campus Citywest, Dublin L2, 24. The company's listed phone number is 353-1468-9000 and its investor relations email address is [email protected] The official website for UDG Healthcare is www.udghealthcare.com.